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Abstract
Background: Chile is currently undergoing a period of rapid demographic transition which has led to an increase in the
proportion of older people in the population; the proportion aged 60 years and over, for example, increased from 8% of the
population in 1980 to 12% in 2005. In an effort to promote healthy ageing and preserve function, the government of Chile has
formulated a package of actions into the Programme of Complementary Feeding for the Older Population (PACAM) which has been
providing a nutritional supplement to older people since 1998. PACAM distributes micronutrient fortified foods to individuals
aged 70 years and over registered at Primary Health Centres and enrolled in the programme. The recommended serving size
(50 g/day) of these supplements provides 50% of daily micronutrient requirements and 20% of daily energy requirements of older
people. No information is currently available on the cost-effectiveness of the supplementation programme.
Aim: The aim of the CENEX cluster randomised controlled trial is to evaluate the cost-effectiveness of an ongoing nutrition
supplementation programme, and a specially designed physical exercise intervention for older people of low to medium socio-
economic status living in Santiago, Chile.
Methods: The study has been conceptualised as a public health programme effectiveness study and has been designed as a 24-
month factorial cluster-randomised controlled trial conducted among 2800 individuals aged 65.0–67.9 years at baseline attending
28 health centres in Santiago. The main outcomes are incidence of pneumonia, walking capacity and change in body mass index
over 24 months of intervention. Costing data (user and provider), collected at all levels, will enable the determination of the
cost-effectiveness of the two interventions individually and in combination. The study is supported by the Ministry of Health in
Chile, which is keen to expand and improve its national programme of nutrition for older people based on sound science-base
and evidence for cost-effectiveness.
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Background and rationale
United Nations estimates show that in 2000, individuals
aged 60 years or older represented 10% of the world's
population, or about 600 million people, and they project
that by the year 2050 this group will represent 22% of the
world's population, or about 2 billion people. Further-
more, the population of individuals aged 80 years or older
is projected to more than triple in the period 2000–2050,
from 1.2% to 4.3% of the world's population, or about 73
million to 400 million people [1]. These changes will be
most dramatic in the less developed countries in Asia and
Latin America, where the population age structure will
change rapidly from one that is predominantly young,
with relatively low proportions of older people, to one
with more balanced numbers across age groups. Promot-
ing good health in later life is desirable whatever the
demographic context, but the growing proportions of
older people make this particularly important now, espe-
cially in low and middle income countries with limited
resources to devote to the care of older people in poor
health. At the 2nd World Assembly on Ageing, policy initi-
atives were proposed to promote active and healthy age-
ing [2]. Emphasis was placed on adequate nutrition
throughout the life course and national food policies
designed to recognise older people as potentially vulnera-
ble.
Current evidence suggests that adherence to a healthy life-
style, including a Mediterranean-style diet high in micro-
nutrients, and moderate levels of physical activity is
associated with considerably enhanced survival chances
in later life [3]. The benefits of micronutrients may well
arise from their role in maintaining immune competence,
and micronutrient supplementation has been demon-
strated to reverse some changes associated with impaired
immunity in older people [4]. The evidence from the few
clinical trials currently available provide mixed results [5].
Physically active people have a healthier and longer life
[6], and a lack of physical exercise in older age is associ-
ated with a higher mortality rate [7]. A recent Cochrane
review of randomised trials of strength training among
older people found that training had a large positive effect
on strength and also had a modest effect on functional
measures such as gait speed and timed chair rise [8]. Mark-
ers of physical function such as gait speed also appear to
be associated with cognitive function in older age [9].
Chile has undergone a period of rapid demographic tran-
sition which has led to an increase in the proportion of
older people in the population: the proportion aged 60
years and over, for example, increased from 8% of the
population in 1980 to 12% in 2005. In an effort to pro-
mote healthy ageing and preserve health and function, the
government of Chile has formulated a package of actions
into the Programme of Complementary Feeding for the Older
Population (PACAM) which has been providing a nutri-
tional supplement, rich in micronutrients, to older people
since 1998. PACAM distributes micronutrient fortified
foods to individuals 70 years and over registered at Pri-
mary Health Centres and enrolled in the programme.
Since mid-2005, beneficiaries of the programme have
been receiving 1 kg of Años Dorados every month, which
provides 400 kcal/100 g, as well as a large array of micro-
nutrients, and 1 kg of Bebida Láctea, a micronutrient forti-
fied milk-based drink. The recommended serving size (50
g/day) of these supplements provide 50% of daily micro-
nutrient requirements and 20% of daily energy require-
ments of older people [10,11].
One of the stated aims of the nutritional supplement is to
improve micronutrient status of older people and thus
enhance health status, potentially via the actions of
micronutrients on immune function. Policy makers and
user groups in Chile have suggested that PACAM would be
enhanced by the inclusion of a regular programme of
physical activity [12]. These combined actions may well
be extremely important as older people in Chile suffer
from high rates of respiratory infections [13] and pneu-
monia is the largest cause of death in people over 80 years
in Chile [14]. Furthermore, according to the 2003
National Health Survey, 95.7% of the Chilean population
over 64 years of age have a sedentary lifestyle [15].
The aim of the CENEX study is to assess whether nutri-
tional supplementation and physical exercise can improve
the health and well-being of older people and prevent dis-
ease and functional disability. Specifically, the project
aims to determine whether a nutrition and exercise inter-
vention will prevent pneumonia and preserve walking
capacity among community-living older people of low to
medium socio-economic status in Santiago, Chile. The
project will also collect information on all costs borne by
both the providers and beneficiaries of the interventions,
in order to determine cost-effectiveness. The study will
serve to examine the programme as currently imple-
mented, inform policy debate on the need to add an exer-
cise component, and provide essential cost-effectiveness
information on two simple interventions aimed at
improving the health and physical function of older peo-
ple.
Methods
Design
The nutritional supplements are distributed to older peo-
ple at health centres, and the study is therefore designed
as a factorial cluster-randomised controlled trial of the
effect of a two year intervention consisting of either a
nutritional supplement, or a resistance training exercise
programme, or both, or neither, on the incidence of pneu-
monia, walking capacity and body mass index amongNutrition Journal 2007, 6:14 http://www.nutritionj.com/content/6/1/14
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adults aged 65.0–67.9 years at baseline living in low to
medium socio-economic status areas of Santiago, Chile.
The procedures are illustrated schematically in Figures 1
and 2, and detailed in the text. On the assumption of no
important interactions between the two interventions on
the primary outcomes, the study aims to test three primary
hypotheses.
Study hypotheses
Provision at health centres of a micronutrient fortified
nutritional supplement for 24 months to adults aged
65.0–67.9 years at baseline will decrease the incidence of
pneumonia among the group of individuals to whom
access to the supplement is offered.
Provision of a community-based, twice-weekly resistance
training exercise programme for 24 months to adults aged
65.0–67.9 years at baseline will increase walking capacity
among individuals to whom access to the programme is
offered.
Provision of a food supplement providing 20% of daily
energy needs in conjunction with an exercise programme
for 24 months to adults aged 65.0–67.9 years at baseline
will not induce weight gain as measured by body mass
index.
Cluster inclusion criteria
• Health centre in Santiago Metropolitan area
• Situated in low-middle socio-economic status munici-
pality
• More than 400 individuals in age-group 65.0–67.9 years
resident in municipality
Participant inclusion criteria
• Resident within catchment area of selected health cen-
tres
• Age 65.0–67.9 at baseline
• Potential national health service (FONASA) beneficiary
Participant exclusion criteria
• Inability to walk unaided
• Having sought medical advice for an un-planned weight
loss of 3 kg in the past 3 months
• Planning to move house in the next 3 months
• Being currently enrolled in PACAM or being current
consumer of Años Dorados and/or Bebida Láctea
• Poor cognitive health (defined low score on cognitive
health screen)
1. Recruitment of health centres (clusters)
Original health centre recruitment plan
This pragmatic trial was designed as a public health pro-
gramme effectiveness study [16] and the interventions
were therefore made available through the established
health system under standard operating procedures, with-
out the use of resource-intensive extraordinary efforts to
secure uptake.
There are 94 health centres in the Santiago Metropolitan
area. The study is aimed at low to medium socio-eco-
nomic status older people, and the nine health centres in
high socio-economic status municipalities were therefore
excluded. The average number of persons aged 65.0–67.9
per health centre was derived from 1992 census data for
each municipality, and small municipalities (those with
less than 400 persons of this age group per health centre)
were excluded (n = 49) in order to facilitate data collec-
tion.
The geographic catchment areas of the remaining 36
health centres in low to medium socio-economic status
areas with sufficient older persons were mapped, and fol-
lowing further discussions and site inspections, 15 health
centres were excluded because of insufficient interest
among health centre staff (self-perception of having heavy
burden of work), or infrastructure limitations, for exam-
ple lack of space to store the nutritional supplement, or no
private room to conduct the interviews. Of the 21 remain-
ing health centres, 20 were randomly assigned, using strat-
ified random sampling, to one of the four treatment arms.
The remaining health centre was kept in reserve in the
event of the withdrawal of a health centre.
Revised health centre recruitment plan
Following the change to the sample size requirement out-
lined below [see Revised sample size calculations for the
nutrition intervention (PACAM)], which required a further
8 clusters to be included, the reserve health centre and the
15 health centres originally excluded were reconsidered
for participation in the study. An additional eight health
centres agreed to take part and could support the limited
data collection required (see Data collection among addi-
tional eight clusters). The eight health centres were ran-
domly assigned, using stratified random sampling, to
either the nutrition intervention arm or the control arm of
the trial.
2. Recruitment of participants
Following the random assignment of the selected health
centres to one of the four trial arms, project field staff ini-
tiated the recruitment of potential participants living inNutrition Journal 2007, 6:14 http://www.nutritionj.com/content/6/1/14
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Flow chart of CENEX Chile protocol for original 20 clusters Figure 1
Flow chart of CENEX Chile protocol for original 20 clusters.
Select participating health centres (n=20)
Randomise health centres to 1 of 4 study arms 
1. Random selection of city blocks within health centre catchment areas 
Systematic search for potential participants (65.0-67.9 years old) 
2. Compile lists of potentially eligible individuals from health centre lists 
Identify potential participants (n=5,000) 
Provide brief information sheets 
Follow-up potential participants (after min. 2 days) by telephone or home visit 
Screen to ensure participant is ambulatory 
Screen for recent weight loss of >3kg over 3 months 
Screen for planned house move to different health centre within 3 months 
Book baseline appointment if participant interested and potentially eligible 
Exclude if non-ambulatory 
and/or >3kg weight loss 
and/or moving house 
Initiate baseline appointment with potential participant 
Provide and explain full information sheets 
If participant willing to enter study screen for cognitive impairment 
Exclude if cognitively impaired 
Request full informed consent 
Enrol in study (n=500 per study arm) 
  Inform participant  Inform participant  Inform participant  Inform participant 
  about access to  about physical  about access to  about need for 24 
  nutrition  exercise sessions  nutrition supplements  month surveillance 
  supplements    and about physical 
     exercise  sessions 
Carry out baseline assessments 
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the health centre catchment areas. Households within the
selected catchment areas, randomly sampled from
detailed maps of city blocks, were visited by project field
staff, and all potentially eligible older people within
selected households were identified. Potential partici-
pants were aged 65.0–67.9 years at baseline: individuals
in this age-group are currently not eligible to receive
PACAM.
A team of 20 project field staff initiated the process of ran-
domly sampling houses in the selected clusters on 4th
May 2005, and after two months the team had sampled
Flow chart of CENEX Chile protocol for additional 8 clusters collecting data for pneumonia outcome only Figure 2
Flow chart of CENEX Chile protocol for additional 8 clusters collecting data for pneumonia outcome only.
Select participating health centres (n=8)
Randomise health centres to 1 of 2 study arms 
Compile lists of potentially eligible individuals from health centre lists 
Identify potential participants (n=1,000) 
Provide brief information sheets 
Follow-up potential participants (after min. 2 days) by telephone or home visit 
Screen to ensure participant is ambulatory 
Screen for recent weight loss of >3kg over 3 months 
Screen for planned house move to different health centre within 3 months 
Book baseline appointment if participant interested and potentially eligible 
Exclude if non-ambulatory 
and/or >3kg weight loss 
and/or moving house 
Initiate baseline appointment with potential participant 
Provide and explain full information sheets 
If participant willing to enter study screen for cognitive impairment 
Exclude if cognitively impaired 
Request full informed consent 
Enrol in study (n=400 per study arm) 
  Inform participant      Inform participant 
  about access to      about need for 24 
 nutrition      month  surveillance 
 supplements     
Carry out baseline assessments 
Collect pneumonia incidence information for 18 months of intervention
Continue to collect pneumonia incidence information for 6 months post-intervention 
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more than 6000 houses and managed to identify 601
potentially eligible individuals. Of these, 351 individuals
stated that they were willing to attend a further appoint-
ment, the majority of the remainder stated that they had
no time (65%) or no interest (35%). Of the 351 individ-
uals expressing an interest, 242 were recruited to the
study. The concomitant availability of 2002 census data
made it clear that adults aged 65–67.9 were spread thinly
and were also unevenly geographically distributed in the
selected clusters. It was therefore decided that a new sam-
pling strategy within clusters was required. The revised
recruitment strategy was based on the gathered evidence
which indicated that 95% of those who had been identi-
fied as potentially eligible via the random sampling pro-
cedure, were also on health centre registries. It was
therefore agreed that the names of older people on regis-
tries held in health centres would be used as the basis for
recruitment.
Potential participants identified by either of these strate-
gies received, on contact, an information sheet outlining
the nature and importance of the study, and were asked
for contact details. The information sheet explicitly stated
which intervention the potential participant would
receive on providing consent to join the study. This
method of randomising clusters prior to identifying par-
ticipants has been shown to result in potential recruit-
ment bias [17], and extra efforts, such as demonstrations
by health workers and public meetings at the health cen-
tres were made to ensure that acceptance rates in the four
study arms were comparable.
Potential participants were then contacted by telephone,
or in person, by a member of the project field staff a min-
imum of two days after receiving the information sheets.
If the potential participant expressed an interest in the
study, they were asked if they were ambulatory (being
able to walk independently and thus complete the physi-
cal assessment required for the exercise intervention), if
they had sought medical advice due to unexplained
weight loss of greater than 3 kg in the past three months
(which may suggest an underlying pathology), or if they
intended to move house (to a different health centre
catchment area) within the next three months. Individu-
als who report that they were non-ambulatory, and/or
had sought medical advice due to unexplained weight
loss, and/or intended to move within the next three
months were not invited to take part in the study and were
thanked for their time and co-operation.
Remaining potential participants were invited to attend
an appointment at a local community centre. Individuals
who were unable to attend the appointment at the com-
munity centre but remained interested in the study were
visited at their homes by a member of the project field
staff. Potential participants were assured (as stated on the
information sheet) that if they did not wish to take part in
the study, it would not prejudice the quality of health care
provision from their health centre. In addition, potential
participants on health centre registries were invited to
informal group meetings to receive information about the
study.
At the baseline appointment (approximately one week
later), potential participants were provided with detailed
information sheets and fully informed by the project field
staff about the nature and relevance of the trial, and
exactly what will be involved if they agreed to take part.
Potential participants were then asked to give consent to
undergo a brief cognitive screen, a short version of the
Mini Mental State Examination (MMSE). The MMSE is an
easy to administer test that has been widely validated as a
screen for dementia [18], and was used to exclude partici-
pants with low cognitive status. Participants with an
MMSE short-version score of less than 13 (out of a maxi-
mum of 19), suggesting possible cognitive impairment,
were further assessed using the 11-item Pfeffer screen [19].
Potential participants scoring six or greater in the Pfeffer
screen were not included in the study, as a short-form
MMSE score of less than 13 combined with a Pfeffer
screen score of six or greater has been validated in Chile as
a marker for possible dementia in adults [20]. Individuals
with an MMSE short version score below 13 and a Pfeffer
screen score of 6 or greater were thanked for their time and
co-operation.
Potential participants who were not excluded for possible
dementia were invited to consent to take part in the study.
Individuals unwilling to participate further were thanked
for their time and co-operation. Individuals giving
informed consent were enrolled in the trial.
All consenting participants were then first assessed by
completing questionnaires in their local community cen-
tre or their homes. They were then invited to attend a local
community centre where they underwent anthropometric
assessment, blood pressure measurement and two brief
mobility tests (see Data Collection). The baseline assess-
ment took approximately 90 minutes to complete and the
anthropometric assessment, blood pressure measurement
and mobility tests took approximately 30 minutes to com-
plete for participants from the original 20 clusters. It took
approximately 45 minutes to collect the limited data
required for the pneumonia outcome in the additional
eight clusters. At this time, participants were informed
about health care provision at their local health centre and
the potential benefits of registration with the National
Health Service. Participants were given contact details for
the study manager, and thanked for their time and co-
operation.Nutrition Journal 2007, 6:14 http://www.nutritionj.com/content/6/1/14
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Interventions
A variety of study outcomes have been identified which
could plausibly be influenced by the interventions. Since
it cannot be assumed that the effects of these two interven-
tions will be additive in all cases, a factorial design with
four distinct study arms is required. The four study arms
are: i. Nutrition intervention (PACAM) alone, ii. Exercise
alone, iii. Nutrition plus exercise and, iv. Control.
Nutrition intervention (PACAM)
PACAM was made available to participants aged 65.0–
67.9 years at baseline who lived within the defined catch-
ment area of the selected health centres. The programme
was provided in its current form as delivered by the Min-
istry of Health. The primary products of PACAM are the
nutritional supplements Años Dorados (a cereal-legume
and vegetable powdered food) and Bebida Láctea (a milk-
based powdered drink), 1 kg of each of which is distrib-
uted to all eligible individuals every month at the health
centre. Detailed nutritional composition of the dietary
supplements is provided in Table 1. Compliance with the
nutrition intervention is assessed by recording the fre-
quency of collection of the supplements from the health
centres, and via specific questions asked at the 12 and 24
month interviews.
Exercise intervention
Participants were individually invited to attend two phys-
ical activity group training sessions per week of one hour
each. Training, supervised by CENEX study physical activ-
ity instructors, consists of a period of warming up and
three levels of chair stands, three levels of modified
squats, three levels of step-ups onto a stair, and six sets of
15 repetitions of arm pull-ups using rubber bands of var-
iable resistance. Special exercises were delivered to partic-
ipants with specific physical limitations. Participants were
encouraged to walk to the exercise classes (up to 20 min-
utes from home) as part of the exercise protocol. Partici-
pants unable to attend classes were advised about
exercises that could be conducted in their homes. Compli-
ance with the exercise intervention is assessed by record-
ing the frequency of attending the training sessions, and
via specific questions asked at the 12 and 24 month inter-
views.
Nutrition plus exercise intervention
Eligible participants received both the nutritional supple-
ment and were invited to attend the exercise intervention
as outlined above.
Control group
Participants in the control group received neither the
nutritional supplement nor were they invited to attend
the exercise intervention. They were however, provided
with the same level of general support and information as
all other study participants and also underwent identical
assessments as all other study participants throughout the
study period.
At the end of the study, all study participants will receive
educational material on healthy ageing and a certificate in
recognition of their participation.
Outcome measures
Primary outcomes for nutrition intervention (PACAM)
The incidence of pneumonia over the 24 months after the
initiation of the intervention.
Operational definition of pneumonia
1. Hospitalised cases of pneumonia – J10-J12 (viral) and
J13-J18 (bacterial) [21]
2. Health centre diagnosed and treated pneumonia – X-
ray confirmed.
Primary outcomes for exercise intervention
Walking capacity (distance walked in six minutes) 24
months after initiation of the intervention.
Secondary outcomes
Body mass index [BMI weight (kg)/height (m)2] as a
measure of potential interaction between the two inter-
ventions.
Incidence of acute respiratory infection.
Measure of self-reported health status (Short-Form 36).
Measure of depression (GDS-15).
Self-reported incidence of chronic diseases (diabetes,
hypertension, coronary heart disease, stroke, heart failure,
arthritic disease) from baseline to 24 months after the ini-
tiation of the intervention.
Physical and functional limitations.
Self reported productive activity in the household and
community.
Self-reported incidence of falls from six months before the
start of the study to 24 months after the initiation of the
intervention.
Self-reported incidence of fracture from 12 months before
the start of the study to 24 months after the initiation of
the intervention.
Blood pressure.Nutrition Journal 2007, 6:14 http://www.nutritionj.com/content/6/1/14
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Anthropometry (waist circumference, triceps skin-fold
thickness, mid-arm circumference, calf circumference,
hand-grip strength.
Timed up-and-go assessment.
Blood indicators of cardiovascular disease risk and insulin
resistance (in a sub-sample).
Sample size calculations
Original sample size calculations
Using data available at the initial planning of the study,
the required sample size was calculated based on the
hypothesised effect sizes, and the likely rates of partici-
pant drop-out for the different outcomes. It was assumed
that there would be no important interactions between
the interventions for the primary outcomes, and that there
might be an interaction for the BMI outcome.
For the pneumonia incidence outcome, the sample size
was calculated based on a comparison of health centre
catchment areas with and without the nutrition interven-
tion. The nutrition intervention was originally planned to
be made available to all eligible adults in the health centre
catchment area and it was originally estimated that 10
health centres providing the nutritional supplement and
10 control health centres would be sufficient to detect a
33% reduction in pneumonia incidence in the health cen-
tre catchment area. This size of reduction was based on the
observed difference in rates of pneumonia between high
and low income groups in Santiago. In order to detect this
effect size with 10 clusters per arm, p < 0.05 and 90%
power and with a coefficient of variation [22] of 19%, 704
person-years of follow-up per cluster were required i.e.
352 participants per cluster over 2 years. Therefore the
minimum 400 available participants per cluster were
defined as more than adequate. The centralised system for
registration of pneumonia cases ensured that loss to fol-
low-up would not affect the capacity of the study to assess
this outcome.
For the walking capacity outcome, the sample size was cal-
culated based on a comparison of health centres with and
without the physical exercise intervention. The mean
change and variability in walking capacity and the coeffi-
cient of variation (78%) was assumed to be the same as
observed in the control arm of a recent trial among older
people in Santiago [23]. In addition it was assumed that
the impact of the intervention would be half that observed
after 18 months in the exercise arms of the same trial i.e.
13% (the trial had more intensive support for participants
than the current study) [23]. In order to detect this effect
size with p < 0.05, 90% power and 10 clusters per arm,
162 person-years of follow-up per cluster were required
Table 1: Nutritional composition of the Años Dorados and Bebida Láctea food supplements used in the Programme for Complementary 
Food in Older People, Chile, 2007
Años Dorados Bebida Láctea
per 100 g per 50 g serving per 100 g per 25 g serving
Energy (kcal) 400 200 406 101.5
Protein (g) 13.0 6.5 18.0 4.5
Total fat (g) 11.0 5.5 10.0 2.5
Carbohydrates (g) 62.3 31.1 61.0 15.3
Total fibre (g) 6.0 3.0 1.0 0.25
Vitamins/minerals
Vitamin A (µg RE) 240.0 120.0 800.0 200.0
Vitamin C (mg) 30.0 15.0 180.0 45.0
Vitamin D (µg) 8.0 4.0 16.0 4.0
Vitamin E (mg TE) 16.0 8.0 32.0 8.0
Vitamin B1 ( m g )0 . 40 . 20 . 80 . 2
Vitamin B2 ( m g )0 . 40 . 21 . 60 . 4
Niacin (mg NE) 4.5 2.3 10.0 2.5
Vitamin B6 ( m g )1 . 00 . 51 . 60 . 4
Folate (µg) 100.0 50.0 400.0 100.0
Vitamin B12 (µg) 1.4 0.7 2.8 0.7
Sodium (mg) 280.0 140.0 540.0 135.0
Calcium (mg) 400.0 200.0 1000.0 250.0
I r o n  ( m g ) 4 . 22 . 15 . 61 . 4
Phosphorus (mg) 400.0 200.0 800.0 200.0
Magnesium (mg) 150.0 75.0 300.0 75.0
Zinc (mg) 3.0 1.5 12.0 3.0
Abbreviations: RE – retinol equivalents; TE – alpha-tocopherol equivalents; NE – niacin equivalentsNutrition Journal 2007, 6:14 http://www.nutritionj.com/content/6/1/14
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i.e. 81 participants per cluster over 2 years. Allowing for
20% drop-out, a sample of 100 participants from each of
10 health centres with equal numbers of controls was
defined as sufficient.
As there may be an interaction between the interventions
for the BMI outcome, the necessary sample size for this
outcome was calculated based on a comparison of health
centres with all combinations of both interventions. The
mean and variability of BMI and the coefficient of varia-
tion (10%) were taken to be the same as observed in the
control arm of the recent trial in Santiago [23]. In order to
detect a 0.5 unit mean change in BMI, with p < 0.05, 90%
power and 5 clusters per arm 64 person-years of follow-up
per cluster were required i.e. 32 participants per cluster
over 2 years. Therefore, the 4 groups of 500 participants
(100 from each of 5 health centres) sampled for the walk-
ing capacity outcome would be more than adequate to
explore an interaction between the two interventions for
this outcome.
The sample size was therefore defined as a total of 2000
individuals drawn from 20 health centres.
A sub-sample of randomly selected participants was
assessed for blood indicators of cardiovascular risk and
insulin resistance under fasting conditions. Assuming a
coefficient of variation of 10%, 80% power, p < 0.05, and
20% drop-out a sample of 120 individuals per study arm
was defined as sufficient to detect a 0.5SD change in these
indicators.
Revised sample size calculations for nutrition intervention (PACAM)
The study was originally designed to provide PACAM to
all eligible individuals between the ages of 65.0 and 67.9
years living within selected clusters and to record all hos-
pital admissions and ambulatory cases of pneumonia
occurring in the clusters. During the implementation of
the study the Chilean Ministry of Health (MOH)
expressed concerns regarding the unpredictable increase
in demand for PACAM and potential greater work load for
health centre staff. It was therefore agreed that rather than
making the nutritional supplement available to all eligi-
ble individuals in the selected clusters, a sample would be
defined that would enable the detection of the proposed
primary outcome regarding pneumonia incidence, (a
reduction of 33% in the incidence of pneumonia in the
PACAM intervention group relative to the control).
Furthermore, during the initial months of the project the
MOH implemented a new model of health insurance,
called AUGE, which provides guaranteed timely access to
health services for specific diseases. The diagnosis and
treatment of ambulatory pneumonia for people over 65
years was included in AUGE which started in June 2005.
This health service advance provided a great opportunity
to enhance the standardization of diagnosis and treat-
ment of pneumonia which was also of direct benefit to
CENEX.
Age-specific figures derived from the first four months of
the CENEX study provided significantly lower estimates of
the incidence of hospitalised pneumonia and also a lower
ratio of ambulatory to hospitalised pneumonia cases than
considered in the original sample size calculation. Con-
sidering these lower rates of pneumonia in the study pop-
ulations, the sample size required to detect the proposed
size effect on pneumonia incidence was re-examined. The
sample size for the primary pneumonia outcome was cal-
culated for a 33% reduction in the 2 year incidence of
pneumonia and was based on the following assumptions:
a) There is a constant ratio of 5:1 for health centre to hos-
pitalised cases of pneumonia.
b) The observed incidence rate of hospitalised pneumonia
of 5 per 1000 in the 65.0–67.9 year old age group will
remain constant throughout the study, (there is seasonal
variation which was taken into account calculating the
expected yearly incidence of pneumonia).
c) All cases of pneumonia recorded in a given health cen-
tre come from that health centre's catchment area (or
address information available).
d) The intra-cluster coefficient of the rate of pneumonia
across the study clusters is 0.001.
In order to detect the proposed effect size with p < 0.05
and 80% power with 10 clusters per arm, 314 person-
years of follow-up per cluster are required i.e. 160 partici-
pants per cluster over 2 years. This increase from 100 to
160 individuals per cluster was deemed unfeasible as
some of the smaller clusters did not have sufficient un-
recruited individuals remaining in the required age group.
In order to detect the proposed effect size with 14 clusters
per arm we require 200 person-years of follow-up per
cluster i.e. 100 participants per cluster over 2 years. The
revised sample size requirement increased to 100 partici-
pants in each of 28 clusters i.e. 2800 participants. The cen-
tralised system for registration of pneumonia cases
ensured that there will be virtually no loss to follow-up for
this outcome.
Recruitment
To obtain a study sample of 2800 individuals, it was
expected that approximately 5000 individuals would
need to be contacted. A conservative estimate of the pro-
portion of potentially eligible individuals who wouldNutrition Journal 2007, 6:14 http://www.nutritionj.com/content/6/1/14
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meet the entry criteria and agree to participate in the study
was 50%.
Recruitment status
Following the revision of the sampling strategy, recruit-
ment of the study sample proceeded well and by 28th
November 2005, 2600 potentially eligible participants
had been identified and by 20th December 2005, 2000
individuals had been recruited to CENEX. Individuals
from the additional eight health centres began to be
recruited on 10th March 2006 and by 2nd June 2006, 800
additional individuals had been recruited to CENEX.
Approximately 70% of eligible individuals agreed to par-
ticipate in the study.
Data collection
Baseline data collection in the original 20 clusters
At the baseline visit, participants were interviewed by
project field staff in their local community centre. Partici-
pants unable to attend their local community centre were
interviewed in their homes by project field staff.
The following information has been collected:
1. Socio-demographic and economic characteristics:
standardised questionnaire on family membership, edu-
cation, marital status, household amenities and tasks,
work history (paid and voluntary), contact with family
members and help given to them, feelings about age,
smoking history and alcohol use. These have been col-
lected in order to help characterise the study population
and as predictors of current and future health status.
2. Self-reported health status: the short-form 36 health
survey (SF-36) [24] which is well validated for use among
adults.
3. Depression: the 15-item Geriatric Depression Scale
(GDS 15) [25] will be used to assess the affective state of
participants. The GDS 15 is quick and easy to administer
and has been validated for use in Chile [26].
4. Self-reported presence of the following medically-diag-
nosed diseases: pneumonia, diabetes, hypertension, coro-
nary heart disease, stroke, heart failure.
5. Self-reported hospitalization within the previous 12
months as a measure of frailty.
6. Self-reported incidence of falls within the previous 6
months and fractures, and 20 year recall of hip and wrist
fracture.
7. Self-reported medications currently being taken on a
daily basis.
8. Self-reported health service utilization to assess direct
and indirect costs borne by participants.
9. Self-reported frequency of consumption of selected
food groups.
10. Self-reported attendance at existing physical exercise
classes.
All participants will then be given a further appointment
to attend a local community centre a few days later where
the following information will be collected by project
field staff:
1. Anthropometry: weight; height; arm, waist, hip and calf
circumferences; triceps skin-fold thickness; knee height;
wrist width; hand-grip strength.
2. Blood pressure measurement: two measurements under
sitting conditions separated by five minutes, using a
sphygmomanometer.
3. Timed up-and-go: the time taken for a participant to
rise from a chair without arm supports, walk three meters,
turn around and return to sit on the chair, which is a good
marker of mobility among older people.
4. 6-minute walk: the maximum distance walked in 6
minutes by a participant, which is a good marker of mus-
cle strength and functional status among older people.
A random sub sample of 120 participants per study arm
will be asked for blood samples (10 ml) collected under
fasting conditions in the early morning in the participant's
home. The samples will be analysed to determine the con-
centrations of: total/HDL/LDL cholesterol, triglycerides,
C-reactive protein, thyroid stimulating hormone, glucose,
insulin and other specific screening markers to determine
susceptibility to chronic disease.
Ambulatory cases of pneumonia will be identified from
health centre records based on the pre-defined AUGE pro-
tocol for ambulatory pneumonia diagnosis and treatment
[27]. In addition, project field staff will review the registry
of all ambulatory admissions to the acute respiratory dis-
ease unit in each health centre, and record all prescrip-
tions for antibiotics given to study participants.
Hospitalised cases of pneumonia among study partici-
pants will be abstracted from computerised Ministry of
Health data. Diagnosis of pneumonia or acute respiratory
infection is initially made by a health centre or hospital
physician blind to whether the participant is enrolled in
the CENEX study. The diagnoses are then independently
confirmed (or otherwise), via patient records, by two phy-
sicians blind to treatment allocation in the CENEX study.Nutrition Journal 2007, 6:14 http://www.nutritionj.com/content/6/1/14
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In order to collect standardised information on the inci-
dence of diseases listed as primary and secondary out-
come variables, the medical records of all study
participants registered in health centres will be reviewed
periodically by project field staff. Uptake by study partici-
pants of PACAM products from the health centres, and
information on attendance of exercise sessions, and any
adverse events during the sessions, will be continually
recorded by project field staff.
Data collection at 12 months in original 20 clusters
All study participants will be interviewed by project field
staff in their local community centre, or visited in their
homes, 12 months after their baseline visit. The following
information will be collected:
1. Self-reported health status: SF36 as at baseline.
2. Depression: GDS15 as at baseline.
3. Cognitive health: MMSE as at baseline and clock-draw-
ing test on random sub-sample
4. Self-reported history of incidence of pneumonia, diabe-
tes, hypertension, coronary heart disease, stroke, heart
failure in the previous 12 months.
5. Self-reported history of falls and fractures in the previ-
ous 12 months.
6. Self-reported health service utilization: as at baseline.
7. Compliance with the interventions: short series of open
and closed questions regarding uptake and utilization of
the interventions.
8. Anthropometry: selected anthropometric measures as
at baseline.
9. Blood pressure measurement: as at baseline.
10. Timed up and go: as at baseline.
Data collection at 24 months in the original 20 clusters
A final evaluation of all study participants will be carried
out after 24 months of intervention. Study participants
will be invited to their local community centre, or visited
in their homes, and assessed for:
1. Selected socio-demographic characteristics and produc-
tive social activity: as at baseline.
2. Depression: GDS15 as at baseline.
3. Self-reported health status: SF36 as at baseline.
4. Cognitive function: as at 12 months.
5. Self-reported presence of medically-diagnosed diseases:
as at baseline.
6. Self-reported hospitalization: as at baseline.
7. Self-reported incidence of falls or fractures in the previ-
ous 12 months.
8. Self-reported medications currently being taken on a
daily basis: as at baseline.
9. Self-reported health service utilization: as at baseline.
10. Compliance with the interventions: as at 12 months.
All participants will then be given an appointment to
attend a local community centre where the following
information will be collected by project field staff:
1. Anthropometry: as at baseline.
2. Blood pressure measurement: as at baseline.
3. Timed up-and-go: as at baseline.
4. 6 minute walk: as at baseline.
Information on incidence of pneumonia will be collected
for 24 months of intervention (including two winter sea-
sons); after this, routine clinic information on pneumonia
incidence will be collected on study participants for a fur-
ther 6 months.
The sub-sample of 120 participants per study arm will be
asked for new blood samples collected under fasting con-
ditions, as at baseline.
Data collection among additional eight clusters
Following identical recruitment and screening procedure
to that undergone by participants in the original 20 clus-
ters, individuals from the additional eight clusters who
provide consent to take part in the study will undergo
baseline assessment at their local community centre or in
their home. Given the late initiation of this additional
sample, participants in the additional eight clusters were
enrolled for 18 months. Information on incidence of
pneumonia will therefore be collected for 18 months of
intervention (including two winter seasons); after this,
routine clinic information on pneumonia incidence will
be collected on study participants for a further 6 months.
The following selected data will be collected at baseline:
1. Basic sociodemographic and economic characteristicsNutrition Journal 2007, 6:14 http://www.nutritionj.com/content/6/1/14
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2. Self-reported health status: SF36
3. Self-reported medications currently being taken on a
daily basis.
4. Self-reported incidence of, and treatment for, pneumo-
nia within the previous 12 months
5. Self-reported smoking and drinking habits
6. Anthropometry: weight, height and hand-grip strength.
7. Blood pressure measurement: two measurements under
sitting conditions separated by five minutes, using a
sphygmomanometer.
Ambulatory and hospitalized cases of pneumonia among
participants in the additional eight clusters will be identi-
fied in an identical manner to that described for the orig-
inal 20 clusters.
Costing data
In order to conduct a cost-effectiveness analysis from the
societal perspective, information on the costs of these
interventions both to the users and the providers is
required. These costs should also be supplemented by the
costs of treating the disease(s) the intervention(s) aims to
avoid and the additional health care the intervention(s)
might trigger. These data will be collected over the inter-
vention period using a range of methods.
User costs will be assessed via:
- exit interviews (duration approximately 20 minutes) of
study participants to ascertain the costs of accessing the
interventions (PACAM and exercise), focussing on the
cost of transportation, the time spent accessing the inter-
ventions for the beneficiaries and any accompanying per-
sons and whether any lost earnings are reported.
- case-based sampling (duration approximately 45 min-
utes) in which individuals who have experienced episodes
of pneumonia and acute respiratory infections will be
identified, contacted and interviewed by telephone, in
order to estimate the costs borne by them, and any car-
egivers. In the interviews, information will be collected on
both hospitalised and non-hospitalised patients, includ-
ing: transportation costs borne by the patient and carer(s);
costs of care, number of days out of work (or other pro-
ductive unpaid activities), income lost by patient and
carer(s).
Provider costs will be assessed via:
- defining the types, quantities and prices of the different
components required to deliver the interventions
(PACAM and exercise) at the health centres and/or com-
munity centres by reviewing expenditure and budget
records.
- case-based sampling, in which the medical records of
individuals who have experienced episodes of pneumonia
and acute respiratory infections will be identified, infor-
mation will be collected on both hospitalised and non-
hospitalised patients, including: length of admission;
number of emergency room visits; drugs consumed and
tests performed.
- analysis of existing data on health centre utilisation rates
will be used to measure differences between the trial arms
and identify unit costs associated with the different serv-
ices provided or averted. The costs of providing these serv-
ices, e.g. diagnoses and treatment for the secondary
outcome variables such as diabetes, hypertension, coro-
nary heart disease, stroke, heart failure and fractures, will
be estimated based on the MOH reference costs (available
on the AUGE website [27]). Because full analysis of the
costs of these secondary outcome variables is beyond the
scope of the current study, the user costs for these services
will be modelled from data collected on pneumonia and
acute respiratory infection cases.
The size of samples required for the collection of these
data, (for example exit interviews of study participants
and review of pneumonia patients' records) will be calcu-
lated once the overall variability of the key measures is
determined.
Data handling
Data acquisition, management and transfer
All study participants will initially be identified by their
unique national identification number (RUT). The RUT
and other person identifying information will be needed
by the project field coordinator and project field staff to
ensure adequate monitoring of participants during the
study. On transfer of data from the project field coordina-
tor to the data coordinating centre at INTA, the RUT and
other person identifying information will be encrypted.
Only the project field coordinator and the data manager
(based at INTA) will have access to person-identifiable
data. Once enrolled onto the study, a unique study
number will be assigned to each study participant which
will be used on all subsequent study documentation.
Only the project field coordinator and the data manager
will have access to the coding sheet linking the unique
study number to person-identifiable data.
Data collected by project field staff will be securely stored
in a locked cabinet by the project field coordinator. AllNutrition Journal 2007, 6:14 http://www.nutritionj.com/content/6/1/14
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data will be transferred on a weekly basis by the project
field coordinator to the data coordinating centre at INTA.
Once at INTA, the data will be entered onto computer and
the data manager will carry out data validation checks and
then feed back any inconsistencies to the project field
coordinator for further action as appropriate.
The data coordinating centre at INTA will be responsible
for logging all data as they arrive and informing the
project field coordinator about any missing data. The data
coordinating centre at INTA will also be responsible for
the safe storage of encrypted and anonymised data for 20
years after the end of the study.
Data analysis
Data analysis will be conducted by statisticians at INTA
and LSHTM who will be blind to the treatment allocation.
The statisticians will prepare interim analyses for the Data
Monitoring Committee as required. The interim analyses
will focus on safety aspects of the interventions.
At the end of the interventions, primary analyses will be
carried out based upon the groups as randomised ("inten-
tion to treat"). Results will be presented as appropriate
effect sizes with a measure of precision (95% confidence
intervals). All analyses will take account of the clustered
design. Covariates will be adjusted for in the analysis as
necessary. Further exploratory analyses will be based on
those participants who fully follow the various treatment
protocols ("per-protocol analyses").
Using the results of the trial and the costing information
collected, the incremental cost-effectiveness of the inter-
ventions will be evaluated. Sensitivity analyses will be per-
formed to assess the robustness of the findings to changes
in key economic and epidemiological parameters. This
approach will facilitate discussions about the generalisa-
bility of the results to other parts of Chile and beyond.
Ethical approval
The protocol for this study has been approved by the Insti-
tutional Review Board at INTA, University of Chile, and
by the LSHTM ethics committee.
Trial organisation
Investigators
1. Professor Ricardo Uauy – senior public health nutri-
tionist at London School of Hygiene & Tropical Medicine
(LSHTM) and Instituto de Nutrición y Tecnología de los
Alimentos (INTA) University of Chile (Principal Investi-
gator)
2. Dr. Cristian Aedo – senior health economist at INACAP
3. Professor Cecilia Albala – senior public health nutri-
tionist at INTA
4. Dr. Alan Dangour – public health nutritionist at
LSHTM
5. Professor Diana Elbourne – senior trialist at LSHTM
6. Professor Emily Grundy – senior demographer at
LSHTM
7. Dr. Damian Walker – health economist at Johns Hop-
kins University.
Project team
1. Dr. Daniel Bunout – senior clinician at INTA
2. Ms. Felicity Clemens – statistician at LSHTM
3. Ms. Alejandra Fuentes – project field manager at INTA
4. Dr. Lydia Lera – statistician at INTA
5. Ms. Ximena Moreno – project field coordinator at INTA
6. Dr. Hugo Sanchez – project manager at INTA
Project Management Group
A Project Management Group (PMG) will run the trial on
a day-to-day basis to ensure the smooth operation of the
project. Regular review meetings will be held with other
members of the team as appropriate. The responsibilities
of the PMG include:
- establishing and monitoring recruitment of participating
centres and participants
- distributing and supplying appropriate documentation
for the trial
- data collection and management
- data entry and cleaning
- data analysis
- organising and servicing the Data Management Commit-
tee.
The PMG will comprise:
Ricardo Uauy (Chair). In Chile: Cecilia Albala, Daniel
Bunout, Hugo Sanchez, Lydia Lera. In the UK/US: Alan
Dangour, Cristian Aedo, Diana Elbourne, Emily Grundy,
Damian Walker.Nutrition Journal 2007, 6:14 http://www.nutritionj.com/content/6/1/14
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An executive committee will be formed comprised of
Ricardo Uauy, Cecilia Albala and Alan Dangour.
Data monitoring committee
An independent Data Monitoring Committee (DMC) has
been established. The membership comprises Dr. R Sali-
nas (Head of Institute of Public Health, and Head of Chile
Centre for Cochrane Iberoamerica Network), Dr. PP
Marin (Professor of Geriatrics, Catholic University Medi-
cal School), and Dr. M Olivares (Permanent Secretary of
the committee on Ethics in Human Research at INTA).
The main aim of the independent DMC is to protect and
serve study participants. The role of the DMC will be
mainly to consider data by group allocation and to make
recommendations to the PMG about whether or not the
trial should continue as planned. The DMC will particu-
larly focus on safety, and recommendations about stop-
ping for effectiveness would be guided by the stringent
Peto-Haybittle rule [28,29]. The DMC will also look at on-
going compliance data to check that a difference in expo-
sure is occurring. If a problem were to be detected, this
could lead to a recommendation to amend aspects of the
protocol. The committee will agree terms of reference and
meet once a year or as they determine.
Publication policy
The primary results of the trial will be published with
authorship in relation to participation in the study, sub-
ject to the approval of the Executive Committee (Uauy,
Albala, Dangour) following discussion with the PMG. All
publications in specific areas of the study or on methodo-
logical aspects may be led by co-investigators in their area
of expertise subject to approval by the Executive Commit-
tee. The requirements for authorship will follow recom-
mended practice in journal guidelines.
Confidentiality
Participants will be identified by their trial number to
ensure confidentiality. However, as the participants in the
trial will be followed for 24 months following randomisa-
tion, it is essential that the project field staff have the
names and addresses of the trial participants recorded on
the data collection forms in addition to the allocated trial
number. Stringent precautions will be taken to ensure
confidentiality of names and addresses. The investigators
and local coordinators will ensure conservation of records
in areas to which access is restricted.
Funding
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Conclusion
Chile is currently undergoing a period of rapid demo-
graphic transition which has led to an increase in the pro-
portion of older people in the population. To support
health in later life, the government of Chile provides a
micronutrient-rich nutritional supplement to older peo-
ple and is planning to expand its programme for older
people to include physical exercise classes. These interven-
tions are designed to impact on the high rates of pneumo-
nia and the low rates of physical activity among older
people in Chile. The current study is designed to test the
cost-effectiveness of Chile's nutritional supplementation
programme and a specially designed exercise package
(either singly or in combination) among 2800 low-mid-
dle socioeconomic status residents of Santiago aged 65.0–
67.9 years. The study is supported by the Ministry of
Health in Chile, which is keen to expand and improve its
programme for older people based on a sound science-
base and evidence for cost-effectiveness. The results of this
study will also be important in the design of public
healthy policy in other countries facing similar demo-
graphic changes.
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